Skip to content

King Pharmaceuticals KG Workers' Compensation — Year 6

Other product segments

General Liability
10.8%
Commercial Auto Liability
8.6%
European Hospital Liability
8.5%
All other lines
-0.9%
International
0.7%

Similar metrics at other companies

CNA Financial logo
CNAWorkers' Compensation — Year 6
3.8%0.0pp
Old Republic International logo
ORIWorkers' Compensation — Year 6
3.9%+0.1pp
The Hartford Financial Services Group logo
HIGWorkers' Compensation — 6th Year
4%0.0pp
United Fire Group logo
UFCSCommercial workers' compensation — Year 6
2.5%+0.1pp
CNA Financial logo
CNAWorkers' Compensation — Year 5
5.8%-0.1pp
CNA Financial logo
CNAWorkers' Compensation — Year 2
24.2%+0.8pp

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's workers' compensation — year 6.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's workers' compensation — year 6?
King Pharmaceuticals (KG) reported workers' compensation — year 6 of 3.4% in Q4 2025.
What does workers' compensation — year 6 mean?
This metric measures the financial results generated by the Workers' Compensation insurance line during the sixth year. It is used to evaluate the segment's stability and its role in the company's broader insurance portfolio.